» Articles » PMID: 16014913

Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers

Overview
Journal J Virol
Date 2005 Jul 15
PMID 16014913
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Although epitope mapping has identified residues on the human papillomavirus (HPV) major capsid protein (L1) that are important for binding mouse monoclonal antibodies, epitopes recognized by human antibodies are not known. To map epitopes on HPV type 6 (HPV6) L1, surface-exposed loops were mutated to the corresponding sequence of HPV11 L1. HPV6 L1 capsomers had one to six regions mutated, including the BC, DE, EF, FG, and HI loops and the 139 C-terminal residues. After verifying proper conformation, hybrid capsomers were used in enzyme-linked immunosorbent assays with 36 HPV6-seropositive sera from women enrolled in a study of incident HPV infection. Twelve sera were HPV6 specific, while the remainder reacted with both HPV6 and HPV11 L1. By preadsorption studies, 6/11 of these sera were shown to be cross-reactive. Among the HPV6-specific sera there was no immunodominant epitope recognized by all sera. Six of the 12 sera recognized epitopes that contained residues from combinations of the BC, DE, and FG loops, one serum recognized an epitope that consisted partially of the C-terminal arm, and three sera recognized complex epitopes to which reactivity was eliminated by switching all five loops. Reactivity in two sera was not eliminated even with all six regions swapped. The patterns of epitope recognition did not change over time in women whose sera were examined 9 years after their first-seropositive visit.

Citing Articles

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection.

Liu X, Chen J, Wang Z, Wang D, He M, Qian C Emerg Microbes Infect. 2019; 8(1):1721-1733.

PMID: 31769733 PMC: 6883418. DOI: 10.1080/22221751.2019.1694396.


The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.

Bissett S, Godi A, Beddows S Sci Rep. 2016; 6:39730.

PMID: 28004837 PMC: 5177933. DOI: 10.1038/srep39730.


Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops.

Fleury M, Nicol J, Samimi M, Arnold F, Cazal R, Ballaire R PLoS One. 2015; 10(3):e0121751.

PMID: 25812141 PMC: 4374900. DOI: 10.1371/journal.pone.0121751.


Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Zhang X, Xin L, Li S, Fang M, Zhang J, Xia N Hum Vaccin Immunother. 2015; 11(5):1277-92.

PMID: 25751641 PMC: 4514273. DOI: 10.1080/21645515.2015.1016675.


Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.

Roberts C, Green T, Hess E, Matys K, Brown M, Haupt R Hum Vaccin Immunother. 2014; 10(8):2168-74.

PMID: 25424920 PMC: 4896759. DOI: 10.4161/hv.29205.


References
1.
Kirnbauer R, Hubbert N, Wheeler C, Becker T, Lowy D, Schiller J . A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst. 1994; 86(7):494-9. PMC: 3935441. DOI: 10.1093/jnci/86.7.494. View

2.
Christensen N, Kirnbauer R, Schiller J, Ghim S, Schlegel R, Jenson A . Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology. 1994; 205(1):329-35. DOI: 10.1006/viro.1994.1649. View

3.
Breitburd F, Kirnbauer R, Hubbert N, Nonnenmacher B, Orth G, Schiller J . Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol. 1995; 69(6):3959-63. PMC: 189126. DOI: 10.1128/JVI.69.6.3959-3963.1995. View

4.
Hofmann K, Cook J, Joyce J, Brown D, Schultz L, George H . Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology. 1995; 209(2):506-18. DOI: 10.1006/viro.1995.1283. View

5.
Heim K, Christensen N, Hoepfl R, Wartusch B, Pinzger G, Zeimet A . Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups. J Infect Dis. 1995; 172(2):395-402. DOI: 10.1093/infdis/172.2.395. View